Premium
The Long‐Acting Thyroid Stimulator and the Result of I 131 Treatment for Thyrotoxicosis
Author(s) -
Martin F. I. R.,
Larkins R. G.,
Alford F. P.,
Andrews J. T.,
Greenberg P. B.,
Melick R. A.,
Penington J. S.
Publication year - 1972
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1972.tb03927.x
Subject(s) - medicine , exophthalmos , thyroid , iodine , endocrinology , surgery , materials science , metallurgy
Summary: Serial assays of the long‐acting thyroid stimulator (LATS) were performed in 93 patients with thyrotoxicosis before and after 5 mCi of l 131 LATS was related to the presence of exophthalmos initially but not to its progress after treatment. LATS was not related to the thyroid status 12 months after l 131 therapy by any means of analysis. The initial plasma protein bound iodine before treatment was correlated positively with continuing thyrotoxicosis at 12 months whereas thyroid size was only significantly related in the group with large (grade 3) goitres.